Currently Viewing:

Top 5 AJMC® Articles of August 2018

AJMC Staff
Here are the top 5 articles for the month of August.


Hi, I’m Jaime Rosenberg for The American Journal of Managed Care®. Here are the top 5 articles for the month of August.

Number 5: In a survey, employers indicated that they are taking a more activist role in delivering healthcare to their employees. They also expressed frustration with the pharmaceutical supply chain and said they expect to see a large uptake of virtual healthcare in the coming years.

Number 4: Ohio announced that it will end its contracts with all of its pharmacy benefit managers and start over with transparent ones.

Number 3: CMS announced that it will end the so-called 25% rule for long-term care hospitals and approved add-on payments estimated to cost about 72 million dollars for CAR T-cell therapy.

Number 2: Celyad’s Investigational New Drug application for CYAD-101 received FDA approval, making it the first non—gene-edited allogeneic clinical program for CAR T-cell therapy.

Number 1: During the Office of the National Coordinator for Health IT’s second Interoperability Forum, CMS administrator Seema Verma painted a future where health data follows the patient and can be shared with a doctor at the click of a button.

To read all of these articles and more, visit

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up